Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...

Merck's Keytruda sales rose 17.2% YoY to $7.43 billion. Find out why MRK stock's strong fundamentals and high dividend yield ...

Supermodel Elle Macpherson has continued to promote her controversial memoir in New York months after claiming she cured her ...

Some 10,000 patients in England are set to get their very own disease-busting jab by 2030, through the NHS Cancer Vaccine ...

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's ...

Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review ...

A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...

Results from a randomized phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy ...

COVID-19’s impact on cancer patients leads to the discovery of immune cells that may help target tumors, potentially offering ...

A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...

Medical Watch Digest for Nov 19 Diabetes increases dementia risk in adults younger than 50 There is a new warning about ...

The ‘We Live in Time’ star, 28, has polycystic ovarian syndrome and endometriosis, both of which can impact fertility ...